NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden

Ferring

Status: Completed

Conditions: Adverse Drug Event

Treatments: Other: LUTS Cohort; Other: NOCDURNA Cohort

Study type: Observational

Funder types: Industry

Identifiers

NCT04740645

000248

Details and patient eligibility

About

A study using medical records to evaluate safety issues for the NOCDURNA drug using national register data from Denmark and Sweden, and a health care register covering parts of Germany.

Enrollment: 1,099,551 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Usage of NOCDURNA recorded as dispensations in adults or usage of drugs for LUTS.

Exclusion criteria

• Multiple dispensations of NOCDURNA on the same day or treatment with vasopressin 6 months before study start.

Trial design

1,099,551 participants in 2 patient groups

NOCDURNA cohort

Treatment:

Other: NOCDURNA Cohort

Lower urinary tract symptoms (LUTS) Cohort

Treatment:

Other: LUTS Cohort